Literature DB >> 5354944

Immunity to staphylococcal infection in mice: effect of living versus killed vaccine, role of circulating antibody, and induction of protection-inducing antigen(s) in vitro.

R D Ekstedt, K Yoshida.   

Abstract

Mice immunized by sublethal doses of living Staphylococcus aureus strains other than the Smith diffuse strain were significantly more resistant to challenge with the Smith diffuse strain than animals immunized with heat-killed organisms. The increased resistance observed was shown, by appropriate passive protection experiments with immune mouse sera, to be due to circulating antibody, probably of the IgM class. In addition, it was observed that strains of S. aureus other than the Smith diffuse strain, when cultured in a modified Staphylococcus 110 broth but not in Brain Heart Infusion, were capable of absorbing protective antibody from hyperimmune rabbit antiserum.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5354944      PMCID: PMC250153          DOI: 10.1128/jb.100.2.745-750.1969

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  9 in total

Review 1.  THE HETEROGENEITY OF THE IMMUNE RESPONSE.

Authors:  J W UHR
Journal:  Science       Date:  1964-07-31       Impact factor: 47.728

2.  The virulence of Staphylococcus pyogenes for man; a study of the problems of wound infection.

Authors:  S D ELEK; P E CONEN
Journal:  Br J Exp Pathol       Date:  1957-12

Review 3.  Cellular reactions in the pathogenesis of staphylococcal infections.

Authors:  L E Cluff
Journal:  Ann N Y Acad Sci       Date:  1965-07-23       Impact factor: 5.691

4.  Mechanisms of resistance to staphylococcal infection: natural and acquired.

Authors:  R D Ekstedt
Journal:  Ann N Y Acad Sci       Date:  1965-07-23       Impact factor: 5.691

5.  Antibody response to Staphylococcus aureus in rabbits: sequence of immunoglobulin synthesis and its correlation with passive protection in mice.

Authors:  K Yoshida; R D Ekstedt
Journal:  J Bacteriol       Date:  1968-11       Impact factor: 3.490

6.  Acute infection of mice with Smith strain of Staphylococcus aureus.

Authors:  G A HUNT; A J MOSES
Journal:  Science       Date:  1958-12-19       Impact factor: 47.728

7.  Relation of mucoid growth of Staphylococcus aureus to clumping factor reaction, morphology in serum-soft agar, and virulence.

Authors:  K Yoshida; R D Ekstedt
Journal:  J Bacteriol       Date:  1968-10       Impact factor: 3.490

8.  Isolation and properties of a surface antigen of Staphylococcus aureus.

Authors:  S I MORSE
Journal:  J Exp Med       Date:  1962-02-01       Impact factor: 14.307

9.  Factors relating to the virulence of Staphylococci. II. Observations on four mouse-pathogenic strains.

Authors:  M G KOENIG; M A MELLY; D E ROGERS
Journal:  J Exp Med       Date:  1962-11-01       Impact factor: 14.307

  9 in total
  11 in total

1.  Safety and immunogenicity of a novel Staphylococcus aureus vaccine: results from the first study of the vaccine dose range in humans.

Authors:  Clayton Harro; Robert Betts; Walter Orenstein; Eun-Jeong Kwak; Howard E Greenberg; Matthew T Onorato; Jon Hartzel; Joy Lipka; Mark J DiNubile; Nicholas Kartsonis
Journal:  Clin Vaccine Immunol       Date:  2010-10-13

2.  Comparison of subcutaneous and intraperitoneal staphylococcal infections in normal and complement-deficient mice.

Authors:  C S Easmon; A A Glynn
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

3.  Induction of resistance with heat-killed compact-type strains of Staphylococcus aureus against challenge with the diffuse variant of the Smith strain of Staphylococcus aureus.

Authors:  K Yoshida; Y Ichiman; T Otomo
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

4.  Virulence of two mastitis strains of Staphylococcus aureus in bovine skin: enhancement by growth in high carbohydrate-high salt medium or in raw milk.

Authors:  J H Brock; A Turvey; B Reiter
Journal:  Infect Immun       Date:  1973-06       Impact factor: 3.441

5.  Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes.

Authors:  P K Peterson; B J Wilkinson; Y Kim; D Schmeling; P G Quie
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

6.  Chemical and biological properties of extracellular slime produced by Staphylococcus aureus grown in high-carbohydrate, high-salt medium.

Authors:  J H Brock; B Reiter
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

7.  Biofilm matrix exoproteins induce a protective immune response against Staphylococcus aureus biofilm infection.

Authors:  Carmen Gil; Cristina Solano; Saioa Burgui; Cristina Latasa; Begoña García; Alejandro Toledo-Arana; Iñigo Lasa; Jaione Valle
Journal:  Infect Immun       Date:  2013-12-16       Impact factor: 3.441

8.  Biological and Immunological Properties of Encapsulated Strains of Staphylococcus aureus from Human Sources.

Authors:  K Yoshida; M R Smith; Y Naito
Journal:  Infect Immun       Date:  1970-11       Impact factor: 3.441

9.  Detection of capsular antigen production in unencapsulated strains of Staphylococcus aureus.

Authors:  K Yoshida; A Nakamura; T Otomo; S Iwami
Journal:  Infect Immun       Date:  1974-04       Impact factor: 3.441

10.  Biological properties of the encapsulated Staphylococcus aureus M.

Authors:  M A Melly; L J Duke; D F Liau; J H Hash
Journal:  Infect Immun       Date:  1974-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.